C12N 2770/32651
Methods of production or purification of viral material
C12N2770/32651 (Methods of production or purification of viral material) appears on 21 US grants and 21 published applications in this corpus.
Search patents in C12N- Granted patents
- 21
- Published applications
- 21
- Assignees
- 27
- Inventors
- 59
- Latest grant
- 27 Feb 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 5 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 2 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 2 |
| 2018 | 2 | 1 |
| 2019 | 1 | 2 |
| 2020 | 0 | 4 |
| 2021 | 2 | 0 |
| 2022 | 0 | 1 |
| 2023 | 1 | 2 |
| 2024 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Process for enterovirus purification and inactivation and vaccine compositions obtained thereof27 Feb 2024US 11,911,457 B2Bharat Biotech International Limited
- Engineered cells with decreased gene expression resulting in increased viral production23 May 2023US 11,655,471 B2University of Georgia Research Foundation, Inc.
- N-antigenic form poliovirus virus-like particles comprising thermostable mutations13 Jul 2021US 11,058,760 B2University of Florida Research Foundation, Inc.
- Processes for production and purification of nucleic acid-containing compositions23 Mar 2021US 10,954,492 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Process for the purification of poliovirus from cell cultures21 May 2019US 10,294,460 B2Janssen Vaccines & Prevention B. V.
- Recombinant enteroviruses and uses thereof27 Jul 2023US 2023/0233669 A1Aleph Therapeutics, Inc.
- Virus purification method using apatite column6 Jul 2023US 2023/0212530 A1Hoya Technosurgical Corporation
- Methods for Inducing a Safe Immune Response Against Polio Virus9 Jun 2022US 2022/0175908 A1Janssen Vaccines & Prevention B. V.
- A process for enterovirus purification and inactivation and vaccine compositions obtained thereof3 Dec 2020US 2020/0376110 A1Bharat Biotech International Limited
- Antigenic thermostable polio vaccines & related methods19 Mar 2020US 2020/0085941 A1Universal Stabilization Technologies, Inc.
Most cited
By later US patents
- Preservation of viruses124US 5,149,653 AQuadrant Bioresources Limited · 1992
- Production of viruses in tissue culture without use of serum39US 4,072,565 AThe Dow Chemical Company · 1978
- Production of poliovirus at high titers for vaccine production32US 8,546,123 B2Crucell Holland B. V. · 2013
- Process for the large-scale production of a vaccine against poliomyelitis and the resulting vaccine27US 4,525,349 ASociete Anonyme dite: Institut Merueux · 1985
- Water purification methods12US 4,054,515 AInternational Telephone and Telegraph Corporation · 1977